Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > 10mg/Vial Retatrutide Peptide, Lyophilized Powder For In Vitro Laboratory Assays
10mg/Vial Retatrutide Peptide, Lyophilized Powder For In Vitro Laboratory Assays buy - large image1
10mg/Vial Retatrutide Peptide, Lyophilized Powder For In Vitro Laboratory Assays buy - image1
10mg/Vial Retatrutide Peptide, Lyophilized Powder For In Vitro Laboratory Assays buy - image2
10mg/Vial Retatrutide Peptide, Lyophilized Powder For In Vitro Laboratory Assays buy - image3
10mg/Vial Retatrutide Peptide, Lyophilized Powder For In Vitro Laboratory Assays buy - image4
10mg/Vial Retatrutide Peptide, Lyophilized Powder For In Vitro Laboratory Assays buy - image5
10mg/Vial Retatrutide Peptide, Lyophilized Powder For In Vitro Laboratory Assays buy - image6

10mg/Vial Retatrutide Peptide, Lyophilized Powder For In Vitro Laboratory Assays

7449 Inquiries

Unit Price:

$53/UNIT EXW

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Research Grade

Content:

99%

Port:

qingdao

Brand:

Peptide

Packaging:

5mg;10mg;15mg;20mg;30mg;40mg;50mg;100mg;500mg

Price valid (until):

2026-11-19

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Cosmetics

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Company Profile

    Our enterprise focuses on developing and supplying synthetic peptide raw materials for life science laboratory research. We have built standardized production workflows and assembled an experienced technical and sales team. We can tailor raw material solutions according to each lab’s experimental design, serving researchers across multiple regions worldwide.

    We uphold integrity and consistent product performance as our core principles. We keep track of evolving needs within the research community and adjust our inventory and supply plans accordingly. From initial consultation and order confirmation through production scheduling and dispatch, we aim to deliver streamlined service for every submission.

    Product Details

    This product line comprises research-grade synthetic peptide lyophilized powder, manufactured via chemical synthesis followed by freeze-drying processing. The lyophilization process lowers moisture levels, slows molecular degradation, and helps preserve material stability over storage.

    Each batch features fine, homogeneous powder that dissolves readily in compatible solvents, with low impurity profiles and consistent performance across production runs. It serves as a reliable material for biochemical assays, in vitro experiments and academic research projects.

    We support small trial batches as well as large-volume orders. Unit pricing becomes more competitive for larger quantities. Custom packaging arrangements can also be discussed to accommodate different laboratory operational preferences.

    Product Consistency

    We maintain careful oversight throughout the whole production workflow. Starting materials are sourced from qualified suppliers and reviewed before entering production.

    Synthesis and purification follow established operating procedures. Finished materials undergo multiple analytical assessments to confirm purity, moisture content and impurity profiles.

    Materials are cleared for dispatch once evaluation criteria are met. Batch records are retained, and relevant supporting documentation can be shared to support your research records upon request.

    Packaging and Logistics

    Our inner packaging uses professional light-blocking sealed vials. Outer packaging includes protective cushioning to reduce mechanical shock and temperature variation risks during transit.

    We work with trusted international logistics partners. Shipment will be arranged within 1–2 business days after payment confirmation, and a tracking number will be provided for shipment monitoring.

    Support Services

    Our sales and technical team provides dedicated support for laboratory buyers and responds to inquiries within 24 business hours.

    You may reach out for guidance on product selection, storage recommendations, order updates or packaging preferences. Custom labeling and repackaging options can be explored where feasible.

    After shipment, we continue tracking delivery progress. Please contact us promptly if any issues arise upon receipt, and we will work toward a suitable resolution.

    Storage Conditions

    Store in a cool, dry, dark, low-temperature environment. Avoid repeated freeze-thaw cycles. We recommend aliquoting materials based on experimental usage to help maintain sample integrity.

    Important Disclaimer

    This product is intended exclusively for in vitro laboratory research. It may NOT be used for human, clinical, diagnostic, medical, cosmetic, food or feed applications. The purchaser shall bear responsibility to ensure the product is used solely within permitted laboratory research scope.

    Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 1 Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 2 Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 3 Shop VIP High Grade Synthetic Lyophilized Peptide for Biochemical Lab Research-Detailed Image 4

    Items Specifications
    Product type Synthetic peptide
    Grade Research grade
    Purity ≥99%
    Appearance White / off‑white lyophilized powder
    Package form Sealed glass vials
    Available experimental sizes 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 100 mg, 500 mg
    Minimum order 1 kit (10 vials)
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Cosmetics

    Location:

    Room 204, Unit 1, Building 3, Liming 1st District, Choujiang Subdistrict, Wenwu City, Jinhua City, China (Zhejiang) Pilot Free Trade Zone

    Year of Establishment:

    2026

  • Inquiry History
    7449 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Hongkong, China

    Retatrutide CAS 2381089-83-2 safe delivery strong Lyophilized powder Vial

    20  Jan 25, 2026
    Singapore

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    100 MG Jun 28, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.